I have come to agree with that last statement you made Seanl as I stated in another post. Big pharma, or big market players will not allow a stock now worth $29M US to accelerate to $2B without a buyout. I hope I'm wrong (I guess), but there is a decent chance of that happening before any pre-efficacy announcement. Why partner when you can just swoop in and buy the farm at this price?
- Forums
- ASX - By Stock
- Nasdaq still gives BNTC a strong Buy rating
I have come to agree with that last statement you made Seanl as...
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)